Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Mazdutide

A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity

Innovent · Phase 2 · Active, not recruiting · Enrollment 141

NCT06862908

ArmPopulationDoseWeeksEstimandWeight change
IBI362 4.0mgObesity or overweight4.0mgn/rn/rn/r
placeboObesity or overweightn/rn/rn/rn/r
IBI362 6.0mgObesity or overweight6.0mgn/rn/rn/r